BioXcel Therapeutics, Inc.

Home » BioXcel Therapeutics, Inc.

IPO

BioXcel Therapeutics, Inc.

They are a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence, or AI, to identify the next wave of medicines across neuroscience and immuno-oncology.

Symbol

BTAI

Price Range
$11.00 - $13.00

Final Shares
5,000,000

Effective Date
March 8, 2018

Underwriters
Barclays, UBS Investment Bank, BMO Capital Markets

To view the prospectus for BioXcel Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253